Insights

Market Position Revance operates in the rapidly expanding biotechnology and aesthetics sector with a strong focus on innovative skincare and sun protection products, making it an attractive partner or customer for advanced formulation, manufacturing, and distribution services.

Product Diversification The company's recent initiatives, including the launch and marketing of Blue Lizard mineral sunscreens and ongoing skincare treatments, present opportunities to explore complementary product development and licensing collaborations.

Growth Opportunities With a revenue range of 250 to 500 million and significant recent investments, Revance is poised for expansion, indicating a need for scalable manufacturing, technological upgrades, and distribution network enhancements.

Regulatory and Legal Environment Ongoing investigations and class action lawsuits suggest a focus on corporate governance and compliance services, offering avenues for legal consultancy, risk management, and reputation management solutions.

Digital Engagement Revance's active online presence, including digital marketing campaigns like billboard promotions for Blue Lizard, opens up possibilities for advertising, marketing technology, and digital content creation partnerships.

Revance Tech Stack

Revance uses 8 technology products and services including jsDelivr, Drupal, Module Federation, and more. Explore Revance's tech stack below.

  • jsDelivr
    Content Delivery Network
  • Drupal
    Content Management System
  • Module Federation
    Development
  • Underscore.js
    Javascript Libraries
  • Web Vitals
    Javascript Libraries
  • Coupa
    Travel And Expense Management
  • YouTube
    Video Players
  • Pinterest
    Visual And User Generated Content Marketing

Media & News

Revance's Email Address Formats

Revance uses at least 1 format(s):
Revance Email FormatsExamplePercentage
First.Last@revance.comJohn.Doe@revance.com
55%
FLast@revance.comJDoe@revance.com
38%
FirstLast@revance.comJohnDoe@revance.com
5%
Last@revance.comDoe@revance.com
2%

Frequently Asked Questions

Where is Revance's headquarters located?

Minus sign iconPlus sign icon
Revance's main headquarters is located at 1222 Demonbreun Street, 20th Floor. The company has employees across 5 continents, including North AmericaEuropeAfrica.

What is Revance's phone number?

Minus sign iconPlus sign icon
You can contact Revance's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Revance's stock symbol?

Minus sign iconPlus sign icon
Revance is a publicly traded company; the company's stock symbol is RVNC.

What is Revance's official website and social media links?

Minus sign iconPlus sign icon
Revance's official website is revance.com and has social profiles on LinkedInCrunchbase.

What is Revance's SIC code NAICS code?

Minus sign iconPlus sign icon
Revance's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Revance have currently?

Minus sign iconPlus sign icon
As of December 2025, Revance has approximately 682 employees across 5 continents, including North AmericaEuropeAfrica. Key team members include Chief Executive Officer: N. M.Cfo & Executive Vice President Corporate Development: L. S.Chief Global Sales Officer & Evp Revance Aesthetics: M. M.. Explore Revance's employee directory with LeadIQ.

What industry does Revance belong to?

Minus sign iconPlus sign icon
Revance operates in the Biotechnology Research industry.

What technology does Revance use?

Minus sign iconPlus sign icon
Revance's tech stack includes jsDelivrDrupalModule FederationUnderscore.jsWeb VitalsCoupaYouTubePinterest.

What is Revance's email format?

Minus sign iconPlus sign icon
Revance's email format typically follows the pattern of First.Last@revance.com. Find more Revance email formats with LeadIQ.

How much funding has Revance raised to date?

Minus sign iconPlus sign icon
As of December 2025, Revance has raised $100M in funding. The last funding round occurred on Mar 04, 2024 for $100M.

Revance

Biotechnology ResearchTennessee, United States501-1000 Employees

We are pleased to announce that Crown Laboratories and Revance Therapeutics are now united as REVANCE.

Section iconCompany Overview

Headquarters
1222 Demonbreun Street, 20th Floor
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
RVNC
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
501-1000

Section iconFunding & Financials

  • $100M

    Revance has raised a total of $100M of funding over 17 rounds. Their latest funding round was raised on Mar 04, 2024 in the amount of $100M.

  • $250M$500M

    Revance's revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $100M

    Revance has raised a total of $100M of funding over 17 rounds. Their latest funding round was raised on Mar 04, 2024 in the amount of $100M.

  • $250M$500M

    Revance's revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.